dantrolene has been researched along with Psychotic Disorders in 8 studies
Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Neuroleptic malignant syndrome is a rare but serious adverse effect of antipsychotic medication." | 2.37 | Neuroleptic malignant syndrome. ( Levenson, JL, 1985) |
| " NMS occurs most often during the first week of treatment or after increasing the dosage of the neuroleptic medication." | 1.43 | [Case report: Neuroleptic malignant syndrome and diagnostic difficulties]. ( Khouri, C; Logerot, S; Mallaret, M; Planès, S; Villier, C, 2016) |
| "Ever since, the concept of catatonia has been the focus of debate, a major point of discussion being its nosological status." | 1.34 | Catatonia and neuroleptic malignant syndrome: two sides of a coin? ( Santens, P; Vancaester, E, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khouri, C | 1 |
| Planès, S | 1 |
| Logerot, S | 1 |
| Villier, C | 1 |
| Mallaret, M | 1 |
| Koychev, I | 1 |
| Hadjiphilippou, S | 1 |
| Lynch, J | 1 |
| Whelan, P | 1 |
| MacCabe, J | 1 |
| Vancaester, E | 1 |
| Santens, P | 1 |
| Gönner, F | 1 |
| Baumgartner, R | 1 |
| Schüpbach, D | 1 |
| Merlo, MC | 1 |
| Sczesni, B | 1 |
| Becker, H | 1 |
| Schröder, J | 1 |
| Bittkau, S | 1 |
| von Baumgarten, F | 1 |
| Truong, DD | 1 |
| Przuntek, H | 1 |
| Levenson, JL | 1 |
| Greenberg, MS | 1 |
| Gorelick, PB | 1 |
| Yamawaki, S | 1 |
| Yanagawa, K | 1 |
| Morio, M | 1 |
| Mori, K | 1 |
1 review available for dantrolene and Psychotic Disorders
| Article | Year |
|---|---|
Neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Child; Dantrol | 1985 |
7 other studies available for dantrolene and Psychotic Disorders
| Article | Year |
|---|---|
[Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
Topics: Antipsychotic Agents; Dantrolene; Female; Humans; Intellectual Disability; Middle Aged; Muscle Relax | 2016 |
Sudden-Onset Catatonia Following Clozapine Withdrawal: A Case Report.
Topics: Antipsychotic Agents; C-Reactive Protein; Catatonia; Clozapine; Creatine Kinase; Dantrolene; Drug Mo | 2016 |
Catatonia and neuroleptic malignant syndrome: two sides of a coin?
Topics: Adult; Aged; Alcoholism; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Brain Injuries; Br | 2007 |
Neuroleptic malignant syndrome during low dosed neuroleptic medication in first-episode psychosis: a case report.
Topics: Adult; Antipsychotic Agents; Clozapine; Dantrolene; Female; Fluphenazine; Humans; Muscle Relaxants, | 1999 |
[Diagnostic and therapeutic aspects of neuroleptic malignant syndrome based on 12 cases].
Topics: Adult; Amantadine; Antipsychotic Agents; Bromocriptine; Dantrolene; Depressive Disorder; Diazepam; D | 1991 |
Rigidity and fever in two psychotic patients.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Dantrolene; Fever; Humans; Male; Muscle Rigidity; Neurol | 1986 |
Possible central effect of dantrolene sodium in neuroleptic malignant syndrome.
Topics: Brain; Dantrolene; Female; Haloperidol; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Psychot | 1986 |